secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2022-11-18T23:59:59+00:00
Accession:  0001022079-22-000157
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics appoints four executive officers to severance plan; amends by-laws
--------------------------------------------------------------------------------

- Four executives appointed as executive officers and Schedule B participants in severance plan: Mark Delaney, Mark Gardner, Karthik Kuppusamy, Patrick Plewman (effective Nov 16, 2022).
- Board amended by-laws on Nov 14, 2022 regarding director nominations, proxy solicitations, and compliance with Rule 14a-19.
- Schedule B participants receive 1x salary + 1x bonus pre-CIC; 2x salary + bonus post-CIC, plus benefits.
- By-law amendments are ministerial, clarifying, and conforming changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000157/0001022079-22-000157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000157/dgx-20221114.htm
  HTML page:      https://secwatch.observer/filing/0001022079-22-000157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer